HU007

DRUG4 trials

Sponsors

Huons Co., Ltd.

Conditions

Dry Eye DiseaseDry Eye SyndromeDry Eye Syndromes

Phase 2

Efficacy and Safety Study of HU00701/HU007 Eye Drops in Patients With Dry Eye Syndrome

CompletedNCT02917512

Huons Co., Ltd.Dry Eye Syndrome

Start: 2016-03-31End: 2016-12-31Updated: 2018-04-12

Phase 3

Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

CompletedNCT03461575

Huons Co., Ltd.Dry Eye Syndrome

Start: 2018-01-22End: 2018-07-12Updated: 2020-05-08

HU007 Eye Drops in Patients With Dry Eye Syndrome

CompletedNCT04384991

Huons Co., Ltd.Dry Eye Syndromes

Start: 2019-05-03End: 2019-12-05Updated: 2020-05-12

HU007 in Patients with Dry Eye Syndrome

CompletedNCT05743764

Huons Co., Ltd.Dry Eye Disease

Start: 2023-03-23End: 2024-02-14Updated: 2024-09-26

Related Papers

A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease

Journal of Ocular Pharmacology and Therapeutics2021-01-1510 citations